Skip to main content
. Author manuscript; available in PMC: 2016 Oct 1.
Published in final edited form as: Schizophr Res. 2015 Sep 2;168(0):456–460. doi: 10.1016/j.schres.2015.08.019

Table 1.

Characteristics of Schizophrenia and Non-Psychiatric Comparison Groups

Sociodemographic Schizophrenia (N = 88) Non-Psychiatric Comparison Subjects (N = 71) t or chi-square p
M or % SD M or % SD
Current Age (Years) 49.4 10.8 50.2 11.5 t = .435 .664
Education (Years) 12.4 2.0 14.7 2.0 t = 7.1 <.001
Gender (% Male) 39.4 - 53.4 - χ2 = 3.1 .079
Race (% Caucasian) 46.6 - 67.6 - χ2 = 7.0 .008
Marital Status (% Single, Never Married) 62.5 - 29.6 - χ2 = 17.1 <.001
Smoking Status (% Current Smokers) 49.4 - 5.6 - χ2 = 35.9 <.001
Age of Schizophrenia Onset (Years) 25.8 11.7 - - - -
Duration of Illness (Years) 23.6 13.3 - - - -
Current Antipsychotic Dose (mg CPZE/day) 565.2 440.8 - - - -
Psychopathology and Cognition
Positive Symptom Factor Score 4.3 3.1 .099 .300 t = −12.6 .001
Negative Symptom Factor Score 7.2 4.5 1.2 1.8 t = −11.2 .001
Disorganized Symptom Factor Score 2.3 1.9 .127 .476 t = −10.3 .001
Executive Functioning Composite Score -.49 .69 .54 .59 t=−9.4 .001
Comorbidity and BMI
CIRS Total Score 7.1 5.0 3.1 3.3 t=6.8 .001
BMI (kg/m2) 31.0 8.3 27.7 7.1 t = −3.4 .001
Lab Values
Fasting Blood Glucose (mg/dL) 103.8 52.6 87.5 13.6 t=2.5 0.013
Hemoglobin A1c (%) 6.2 1.2 5.6 0.3 t=3.4 0.001
hs-CRP (mg/L) 4.3 5.4 2.3 3.8 t = −3.9 .001

Note:

BMI = Body Mass Index

CIRS = Cumulative Illness Rating Scale

CPZE = Chlorpromazine Equivalent

hs-CRP = high sensitivity C-Reactive Protein

HHS Vulnerability Disclosure